Holista Colltech Ltd Suspension Continues
Key points
- Holista Colltech Ltd securities halted on 8 April 2026
- Suspension continued as company unable to release announcement
- Suspension will continue until ASX satisfied company complies with Listing Rules
Full summary
Holista Colltech Ltd's (HCT) securities were halted on 8 April 2026 at the request of the company under Listing Rule 17.1. This was pending the release of an announcement regarding a legal matter with ProImmune Company LLC. HCT's securities were subsequently suspended from quotation at the request of the company under Listing Rule 17.2 on 10 April 2026 when HCT was unable to release an announcement to the market to lift the trading halt. As HCT is yet to release an announcement that will result in the reinstatement of its securities, the securities of HCT will remain suspended from quotation in accordance with Listing Rule 17.3. The suspension will continue until ASX is satisfied that HCT is in compliance with the Listing Rules, including Listing Rule 3.1, and that it is otherwise appropriate for HCT's securities to be reinstated to quotation.
Summary generated by a large language model. Please interpret with care.